Vitiligo antibodies are not directed to tyrosinase

Archives of Dermatology

Volumn 135, Issue 4, 1999, Pages 417-422

  Xie, Zhong ^a   Chen, Dunlu ^a   Jiao, Diane ^a   Bystryn, Jean Claude ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; MONOPHENOL MONOOXYGENASE;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOCYTE; PATHOGENESIS; PRIORITY JOURNAL; VITILIGO;

EID: 0032938837     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.135.4.417     Document Type: Article

References (25)

1. Naughton GK, Eisinger M, Bystryn JC. Detection of antibodies to melanocyte in vitiligo by specific immunoprecipitation. J Invest Dermatol. 1983;81:540-542.
2. Bystryn J-C. Immune mechanisms in vitiligo. In: Hann S-K, ed. Clinics in Dermatology. New York, NY: Elsevier Science Inc; 1997:853-861.
3. Naughton GK, Eisinger M, Bystryn J-C. Antibodies to melanocyte in vitiligo. J Exp Med. 1983;158:246-251.
4. Naughton GK, Reggiardo MD, Bystryn J-C. Correlation between vitiligo antibodies and extent of depigmentation in vitiligo. J Am Acad Dermatol. 1986;15:978-981.
5. Naughton GK, Mahaffey M, Bystryn J-C. Antibodies to surface antigens of pigment cells in animals with vitiligo. Proc Soc Exp Biol Med. 1986;181:423-426.
6. Galbraith GM, Miller D, Emerson DL. Western blot analysis of serum antibody reactivity with human melanoma cell antigens in alopecia areata and vitiligo. Clin Immunol Immunopathol. 1988;48:317-324.
7. Harning R, Cui J, Bystryn J-C. Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo. J Invest Dermatol. 1991;97: 1078-1080.
8. Cui J, Arita Y, Bystryn J-C. Cytolytic antibodies to melanocyte in vitiligo. J Invest Dermatol. 1993;100:812-815.
9. Norris DA, Kissinger RM, Naughton GK, Bystryn J-C. Evidence for immunologic mechanisms in human vitiligo: patients' sera induce damage to human melanocyte in vitro by complement-mediated damage and antibody-dependent cellular toxicity. J Invest Dermatol. 1988;90:783-789.
10. Cui J, Chen D, Misfeldt ML, Swinfard RW, Bystryn J-C. Antimelanoma antibodies in swine with spontaneously regressing melanoma. Pigment Cell Res. 1995; 8:60-63.
11. Song Y, Connor E, Li Y, Zorovich B, Balducci P, Maaclaren N. The role of tyrosinase in autoimmune vitiligo. Lancet. 1994;344:1049-1052.
12. Baharav E, Merimski O, Shoenfeld Y, et al. Tyrosinase as an autoantigen in patients with vitiligo. Clin Exp Immunol. 1996;105:84-88.
13. 35S-labeled recombinant human tyrosinase in a radioimmunoassay. J Invest Dermatol. 1997;109: 69-73.
14. Eisinger M, Marko O. Selective proliferation of normal human melanocyte in vitro in the presence of phorbol ester and cholera toxin. Proc Natl Acad Sci U S A. 1982;79:2018-2122.
15. Tobin DT, Colen SR, Bystryn J-C. Isolation and long-term culture of human hairfollicle melanocyte. J Invest Dermatol. 1995;104:86-89.
16. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
17. Cuomo M, Nicotra MR, Apollonj C, et al. Production and characterization of murine monoclonal antibody 2G10 to a human T4-tyrosinase epitope. J Invest Dermatol. 1991;96:446-451.
18. Vachtenheim J, Duchon J, Matous B. Tyrosinase of hamster melanoma: its purification and estimation by radioimmunoassay. Comp Biochem Physiol B Mol Biol. 1987;87:709-714.
19. Nishioka K. Particulate tyrosinase of human malignant melanoma: solubilization, purification following trypsin treatment, and characterization. Eur J Biochem. 1978;85:137-146.
20. Hearing VJ, Ekel TM, Montague PM. Mammalian tyrosinase: isozymic forms of the enzyme, Int J Biochem. 1981;13:99-103.
21. Wittbjer A, Dahlback B, Odh G, et al. Isolation of human tyrosinase from cultured melanoma cells. Acts Derm Venereol. 1989;69:125-131.
22. Wittbjer A, Odh G, Rosengren AM, et al. Isolation of soluble tyrosinase from human melanoma cells. Acts Derm Venereol. 1990;70:291-294.
23. Yurkow EJ, Laskin JD. Purification of tyrosinase to homogeneity based on its resistance to sodium dodecyl sulfate-proteinase K digestion. Arch Biochem Biophys. 1998;275:122-129.
24. Cui J, Harning R, Henn M, Bystryn J-C. Identification of pigment cell antigens defined by vitiligo antibodies. J Invest Dermatol. 1992;98:162-165.
25. Howanitz N, Nordlund JJ, Lerner AB, Bystryn J-C. Antibodies to melanocytes in patients with vitiligo and chronic mucocutaneous candidiasis. Arch Dermatol. 1981;117:705-708.